PDM-ProValue meets cardiovascular outcome trials in diabetes

Novel studies have increased our knowledge regarding optimal treatment options in diabetes. Key studies that have broadened our knowledge about optimal treatment options in diabetes in recent years are cardiovascular outcome trials (CVOTs) and studies investigating aspects of digitalisation and moni...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritzen, Katharina, Schnell, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348620/
https://www.ncbi.nlm.nih.gov/pubmed/30691463
http://dx.doi.org/10.1186/s12933-019-0815-3
_version_ 1783390130170494976
author Fritzen, Katharina
Schnell, Oliver
author_facet Fritzen, Katharina
Schnell, Oliver
author_sort Fritzen, Katharina
collection PubMed
description Novel studies have increased our knowledge regarding optimal treatment options in diabetes. Key studies that have broadened our knowledge about optimal treatment options in diabetes in recent years are cardiovascular outcome trials (CVOTs) and studies investigating aspects of digitalisation and monitoring of glucose (e.g. PDM-ProValue). We aimed at highlighting similarities between the two important pillars for a successful diabetes management. We emphasise the need for a consideration of both approaches in future clinical trial designs and protocols.
format Online
Article
Text
id pubmed-6348620
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63486202019-01-31 PDM-ProValue meets cardiovascular outcome trials in diabetes Fritzen, Katharina Schnell, Oliver Cardiovasc Diabetol Commentary Novel studies have increased our knowledge regarding optimal treatment options in diabetes. Key studies that have broadened our knowledge about optimal treatment options in diabetes in recent years are cardiovascular outcome trials (CVOTs) and studies investigating aspects of digitalisation and monitoring of glucose (e.g. PDM-ProValue). We aimed at highlighting similarities between the two important pillars for a successful diabetes management. We emphasise the need for a consideration of both approaches in future clinical trial designs and protocols. BioMed Central 2019-01-28 /pmc/articles/PMC6348620/ /pubmed/30691463 http://dx.doi.org/10.1186/s12933-019-0815-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Fritzen, Katharina
Schnell, Oliver
PDM-ProValue meets cardiovascular outcome trials in diabetes
title PDM-ProValue meets cardiovascular outcome trials in diabetes
title_full PDM-ProValue meets cardiovascular outcome trials in diabetes
title_fullStr PDM-ProValue meets cardiovascular outcome trials in diabetes
title_full_unstemmed PDM-ProValue meets cardiovascular outcome trials in diabetes
title_short PDM-ProValue meets cardiovascular outcome trials in diabetes
title_sort pdm-provalue meets cardiovascular outcome trials in diabetes
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348620/
https://www.ncbi.nlm.nih.gov/pubmed/30691463
http://dx.doi.org/10.1186/s12933-019-0815-3
work_keys_str_mv AT fritzenkatharina pdmprovaluemeetscardiovascularoutcometrialsindiabetes
AT schnelloliver pdmprovaluemeetscardiovascularoutcometrialsindiabetes

Ejemplares similares